At the beginning of the pandemic, we took decisive steps to help people with diabetes by releasing the special STAYHOME code, which unlocks all of Diabetes:M’s Premium functionality for free until June the 16th. For more information check our COVID-19 response page.

Today, together with the world’s leading diabetes organizations, Sirma Medical Systems is sharing guidance on high-impact COVID-19 prevention recommendations for people with diabetes. The recommendations aim to keep the most vulnerable to complications from COVID-19 safe until the pandemic has been contained. The recommendations were created by the JDRF – Beyond Type 1 Alliance and are also endorsed by the American Diabetes Association, Harvard Medical School, and The International Society for Pediatric and Adolescent Diabetes (ISPAD). They can be found at

Members of the diabetes community are among the most vulnerable to serious complications and death caused by coronavirus. While not everyone with diabetes — Type 1 or Type 2 — has the same level of risk, the recommendations target broad changes in behavior from everyone in the diabetes community to protect those members of the community who are the most at risk.

“We are happy to be a part of this global effort. COVID-19 is affecting all aspects of our lives, and it is great to see so many organizations from all around the world join together towards a single goal. It will take all of us to curb the spread, and we will do our part gladly”, said Rossen Varbanov, CEO of the company.

It is estimated that 463 million adults worldwide are living with diabetes. To reach this vast network, a global digital campaign has been launched with the help of partner organizations around the world. The website and campaign materials are available in Spanish and English, with a goal of translation into as many languages as possible.

Along with the list of recommendations, the website includes a variety of other articles, downloadable graphics, videos and links to additional resources provided by JDRF, Beyond Type 1, and other partners. Organizations and companies looking to help in the effort can reach out to



Diabetes:M was first published in Google Play in April, 2013. It was developed by diabetics to meet the needs of people who want to manage all aspects of their condition. Users can track, analyze, review and export data in great detail, as well as share information with their doctors. Today Diabetes:M is an established tool with over 500 000 installations and more than 50 000 active users. The application is well known to medical professionals, with many diabetes specialists recommending it to their patients.

Download on the App Store:

Get it on Google Play:

Leave a Reply

Your email address will not be published. Required fields are marked *

Post comment